Inhibitors | Comment | Organism | Structure |
---|---|---|---|
additional information | the ligand binding site is located at the interface between the two monomers and includes the catalytic triplet, Asp-Thr-Gly, conserved in all aspartic proteases. Detection of structural local asymmetry in the PR2 dimer complexed with a diversified set of ligands, quantification of the structural asymmetry of the PR2 set, overview | Human immunodeficiency virus 2 |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Human immunodeficiency virus 2 | P04584 | Gag-Pol polyprotein; HIV-2 | - |
Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|
additional information | PR2 recognizes various non-homologous substrates (Gag and Pol polyproteins) at several cleavage sites and protease inhibitors | Human immunodeficiency virus 2 | ? | - |
? |
Subunits | Comment | Organism |
---|---|---|
homodimer | - |
Human immunodeficiency virus 2 |
Synonyms | Comment | Organism |
---|---|---|
HIV-2 protease | - |
Human immunodeficiency virus 2 |
PR2 | - |
Human immunodeficiency virus 2 |
General Information | Comment | Organism |
---|---|---|
additional information | PR2 is an aspartic protease corresponding to a C2-symmetric homodimer of 99 residues in each monomer. The ligand binding site is located at the interface between the two monomers and includes the catalytic triplet, Asp-Thr-Gly, conserved in all aspartic proteases. Detection of structural local asymmetry in the PR2 dimer complexed with a diversified set of ligands, global structural asymmetry of PR2 dimers, overview | Human immunodeficiency virus 2 |
physiological function | HIV PR2 is essential for hydrolysing the viral Gag and the Gag-Pol precursor polyproteins during the maturation of infectious viral particles | Human immunodeficiency virus 2 |